Press Releases about Lexaria Bioscience Corp
Lexaria Bioscience (NASDAQ: LEXX) Optimistic of Positive Study Results
February 28, 2022
![]() Via AccessWire
![]()
Lexaria Provides Annual Letter From the CEO
January 27, 2022
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|